Navigation Links
DuraHeart(TM) LVAS Receives Conditional Approval for US Pivotal Trial
Date:3/3/2008

ANN ARBOR, Mich., March 3 /PRNewswire/ -- Terumo Heart, Inc. announced today that they have received conditional approval from the Food and Drug Administration (FDA) to begin enrollment in the US Pivotal Trial of the DuraHeart (TM) LVAS for a Bridge-to-Transplant (BTT) indication.

(Logo: http://www.newscom.com/cgi-bin/prnh/20070227/CLTU043LOGO )

(Photo: http://www.newscom.com/cgi-bin/prnh/20080303/CLM012 )

Dr. David Munjal, Vice President of Clinical Studies, Regulatory Affairs and Quality Systems at Terumo Heart, Inc., commented: "We are extremely pleased that FDA has allowed us to move directly to the Pivotal Trial based on our existing European data. The conditional approval was granted pending answers to some additional questions. Terumo Heart, Inc. has already responded to the FDA concerning these questions and final approval is anticipated in the near future."

Dr. Chisato Nojiri, M.D., Ph.D., Chief Executive Officer for Terumo Heart, Inc., said: "The approval of the IDE Pivotal Trial is a major milestone for Terumo Heart and we are especially pleased that the FDA has also issued approval for patients to be discharged home. This positive decision by the FDA was based on our robust preclinical data and the successful European clinical trial of the DuraHeart System."

The Pivotal Trial will be a multi-center, prospective, non-randomized study of 140 patients and will include up to 40 centers. The Principal Investigators will be Francis Pagani, M.D., Ph.D., from the University of Michigan and Yoshifumi Naka, M.D., Ph.D., from Columbia Presbyterian Hospital in New York.

The DuraHeart LVAS is a third generation circulatory support device intended to provide cardiac support for patients who are at risk of death due to end-stage left ventricular failure. It i
'/>"/>

SOURCE Terumo Heart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Terumo Heart Reports Summary of DuraHeart(TM) LVAS Clinical Trial Results
2. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
3. Vermillion Receives Award From the Society of Gynecologic Oncologists
4. Arbios Receives Conditional Approval from the FDA to Initiate Pivotal Clinical Trial for SEPET(TM)
5. ActivBiotics Receives Orphan Drug Designation from the European Medicines Agency for Superoxide Dismutase Mimetic, M40403, in Oral Mucositis Indication
6. Thalidomide Pharmion(R) Receives Positive Opinion for Treatment of First-line Multiple Myeloma from European Medicines Agency
7. Peregrine Pharmaceuticals Receives Approval to Conduct a Second Phase II Trial of Bavituximab in Patients With Advanced Breast Cancer
8. Photo: Welchol(TM) (colesevelam HCl) Receives FDA Approval to Reduce Blood Glucose in Adults with Type 2 Diabetes
9. Peregrine Pharmaceuticals Receives Approval to Conduct a Phase II Trial of Bavituximab in Patients With Non-Small Cell Lung Cancer
10. Abbotts HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
11. Vical Receives Payment from AnGes MG for Allovectin-7(R) Phase 3 Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... 24, 2014 IGI Laboratories, Inc. (NYSE MKT: ... specialty generic pharmaceutical company, today announced it has accepted  ... Directors.  Mr. Finio has accepted a senior level finance ... of his acceptance of his new position, Mr. Finio ... Director for IGI Laboratories, Inc.  The effective date of ...
(Date:7/24/2014)... July 24, 2014 Many new dentists who are ... to ensure that their practice will be a success. DentalDisposables.net ... supplies they use the most can make all the difference. ... have recently discovered that purchasing discount dental supplies ... According to successful dentists across the United ...
(Date:7/24/2014)... , July 24, 2014  Perrigo Company (NYSE: ... has received an AB therapeutic equivalent rating from the ... approved New Drug Application (NDA) for testosterone gel 1.0%. ... to [AbbVie,s] AndroGel 1% and can be substituted with ... clinical effect and safety profile as AndroGel 1% when ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Change To Its Board Of Directors 2Dental Supplies Online is Key to Dental Success...Really! 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3
(Date:7/24/2014)... 2014 A few weeks have passed ... incredible high jump by Inika McPherson is a feat ... the USATF National Championships hosted the best track and ... McPherson, won US Nationals with the 2nd best jump ... for the biggest height over head jump in history. ...
(Date:7/24/2014)... 2014 Voted one of the most ... clients, BellasDress focuses on providing its new and old ... Recently, the company has announced its new collection of ... range is created according to the latest fashion trends. ... to 68% off. , As a matter of fact, ...
(Date:7/24/2014)... July 24, 2014 The federal ... ) in the U.S. District Court, District ... for plaintiff medical information covered by the federal ... the July 16th Order, U.S. District Judge Douglas ... Fresenius Medical Care the right to receive HIPAA- ...
(Date:7/24/2014)... (PRWEB) July 24, 2014 CarePoint ... specialist in hematology and oncology, Dr. Hitendra Upadhyaya, ... Our system welcomes Dr. Upadhyaya to the community. ... CarePoint Health Medical Group, a comprehensive network of ... a wide range of specialties. This latest acquisition ...
(Date:7/24/2014)... BUFFALO, N.Y. Primary care treatment of overweight and ... and child compared to when only the child is ... Pediatrics and conducted at the University at Buffalo ... in this study were overweight or obese and had ... was overweight or obese, according to body mass index ...
Breaking Medicine News(10 mins):Health News:Setting A New High Jump World Record In Zensah® Compression 2Health News:Setting A New High Jump World Record In Zensah® Compression 3Health News:BellasDress Helps Brides Get High End Wedding Dresses for Their Romantic Weddings 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 2Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 3Health News:GranuFlo Lawsuits Move Forward in Federal Court, With Issuance of Protective Order for HIPAA Information, Bernstein Liebhard LLP Reports 4Health News:Dr. Upadhyaya Joins CarePoint Health Medical Group 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 2Health News:Overweight and obese preschoolers lose more weight when parent is also treated 3
... , , STEWARTVILLE, Minn., July 30 Rochester ... third quarter ended June 30, 2009. , , The Company ... third quarter of last year. The Company also reported net loss of ... of $312,000 or $.02 per diluted share for the same period of last ...
... INDIANAPOLIS, July 30 WellPoint, Inc. (NYSE: ... for the administration of the H1N1 (swine flu) vaccine when ... administration will be covered for members whose benefit plans provide ... also continue coverage of seasonal flu vaccine administration for those ...
... , , , , ... today reported revenue for the second quarter of 2009 of $41.0 million. ... to revenue of $42.1 million and a net loss of $7.7 million, ... , Excluding amortization of purchased intangible assets, stock compensation and ...
... shows they,re at increased risk of psychological distress years ... survivors are more likely than their healthy peers to ... even a decade after treatment ends, new research shows. ... of diagnosis, unmarried, had less than a high school ...
... , Perkins challenges Planned Parenthood President to Debate ... Research Council Action President Tony Perkins today urged the House Energy ... of health care providers and ensure that Americans, tax dollars are ... Perkins also responded to attacks by Planned Parenthood and the ...
... , WASHINGTON, July 30 An estimated ... if Congress passes a House health reform bill, according to ... 2009 released this week by The Heritage ... The Lewin Group , a highly respected health ...
Cached Medicine News:Health News:Rochester Medical Reports Third Quarter Results 2Health News:Rochester Medical Reports Third Quarter Results 3Health News:Rochester Medical Reports Third Quarter Results 4Health News:Rochester Medical Reports Third Quarter Results 5Health News:Rochester Medical Reports Third Quarter Results 6Health News:Rochester Medical Reports Third Quarter Results 7Health News:Rochester Medical Reports Third Quarter Results 8Health News:Rochester Medical Reports Third Quarter Results 9Health News:Rochester Medical Reports Third Quarter Results 10Health News:Rochester Medical Reports Third Quarter Results 11Health News:WellPoint Announces Decision to Cover H1N1 Vaccine Administration 2Health News:Cepheid Reports 2009 Second Quarter Results 2Health News:Cepheid Reports 2009 Second Quarter Results 3Health News:Cepheid Reports 2009 Second Quarter Results 4Health News:Cepheid Reports 2009 Second Quarter Results 5Health News:Cepheid Reports 2009 Second Quarter Results 6Health News:Cepheid Reports 2009 Second Quarter Results 7Health News:Cepheid Reports 2009 Second Quarter Results 8Health News:Cepheid Reports 2009 Second Quarter Results 9Health News:Cepheid Reports 2009 Second Quarter Results 10Health News:Cepheid Reports 2009 Second Quarter Results 11Health News:Cepheid Reports 2009 Second Quarter Results 12Health News:Cepheid Reports 2009 Second Quarter Results 13Health News:Cepheid Reports 2009 Second Quarter Results 14Health News:Cepheid Reports 2009 Second Quarter Results 15Health News:Cepheid Reports 2009 Second Quarter Results 16Health News:Cepheid Reports 2009 Second Quarter Results 17Health News:Cepheid Reports 2009 Second Quarter Results 18Health News:Cancer Survivors Face Tough Road Long After Treatment Ends 2Health News:Cancer Survivors Face Tough Road Long After Treatment Ends 3Health News:FRC: The Truth Hurts Planned Parenthood and NARAL 2Health News:Millions of Virginians Could Lose Private Insurance, Study Shows 2
Intended for the quantitative determination of aspartate aminotransferase activity in serum or plasma. Reaction: Kinetic. Wavelength: 340 nm. Linearity: 268 U/L at 30C. Two vials, dry powder reagents...
... The DRS 2000, a uniquely intelligent system, ... its space saving, 2-level design. Up to 27 ... to give you the flexibility to tailor your ... lab. Two start stations allow for continuous loading; ...
... latest from the leader in automatic slide ... modern approach to slide staining, ending messy ... blood smears, bone marrow and other body ... Aerospray stainer becomes a superb cytocentrifuge with ...
Cholesterol FS. For determination of cholesterol in serum or plasma. Available with Calibrator: Trucal U and Controls: Trulab N, Trulab P Trulab L....
Medicine Products: